nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP2B6—Thiotepa—urinary bladder cancer	0.118	0.15	CbGbCtD
Rilpivirine—ABCB1—Mitomycin—urinary bladder cancer	0.0796	0.101	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—urinary bladder cancer	0.0648	0.0823	CbGbCtD
Rilpivirine—ABCG2—Fluorouracil—urinary bladder cancer	0.0543	0.0691	CbGbCtD
Rilpivirine—ABCG2—Carboplatin—urinary bladder cancer	0.054	0.0687	CbGbCtD
Rilpivirine—ABCG2—Cisplatin—urinary bladder cancer	0.0462	0.0587	CbGbCtD
Rilpivirine—ABCG2—Etoposide—urinary bladder cancer	0.0454	0.0577	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0377	0.048	CbGbCtD
Rilpivirine—CYP3A4—Thiotepa—urinary bladder cancer	0.0361	0.0459	CbGbCtD
Rilpivirine—CYP2B6—Cisplatin—urinary bladder cancer	0.0325	0.0413	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—urinary bladder cancer	0.0309	0.0393	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—urinary bladder cancer	0.03	0.0381	CbGbCtD
Rilpivirine—ABCB1—Gemcitabine—urinary bladder cancer	0.0229	0.0291	CbGbCtD
Rilpivirine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0224	0.0285	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0218	0.0277	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—urinary bladder cancer	0.0187	0.0238	CbGbCtD
Rilpivirine—ABCB1—Cisplatin—urinary bladder cancer	0.0166	0.0212	CbGbCtD
Rilpivirine—ABCB1—Etoposide—urinary bladder cancer	0.0164	0.0208	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—urinary bladder cancer	0.0112	0.0142	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—urinary bladder cancer	0.0108	0.0137	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—urinary bladder cancer	0.0098	0.0125	CbGbCtD
Rilpivirine—Pazopanib—FGFR3—urinary bladder cancer	0.0081	1	CrCbGaD
Rilpivirine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00668	0.0085	CbGbCtD
Rilpivirine—CYP2C19—urine—urinary bladder cancer	0.00256	0.154	CbGeAlD
Rilpivirine—CYP1A2—urine—urinary bladder cancer	0.00209	0.126	CbGeAlD
Rilpivirine—CYP3A4—urine—urinary bladder cancer	0.00151	0.0912	CbGeAlD
Rilpivirine—Opportunistic infection—Methotrexate—urinary bladder cancer	0.00125	0.0119	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Thiotepa—urinary bladder cancer	0.00124	0.0118	CcSEcCtD
Rilpivirine—SLCO1B3—vagina—urinary bladder cancer	0.0012	0.0725	CbGeAlD
Rilpivirine—Hepatotoxicity—Cisplatin—urinary bladder cancer	0.00119	0.0113	CcSEcCtD
Rilpivirine—Opportunistic infection—Epirubicin—urinary bladder cancer	0.00117	0.0111	CcSEcCtD
Rilpivirine—Infection—Carboplatin—urinary bladder cancer	0.00111	0.0106	CcSEcCtD
Rilpivirine—Hepatotoxicity—Etoposide—urinary bladder cancer	0.00109	0.0104	CcSEcCtD
Rilpivirine—Opportunistic infection—Doxorubicin—urinary bladder cancer	0.00108	0.0103	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Gemcitabine—urinary bladder cancer	0.00104	0.00991	CcSEcCtD
Rilpivirine—Creatinine increased—Gemcitabine—urinary bladder cancer	0.00104	0.00984	CcSEcCtD
Rilpivirine—Inflammation—Fluorouracil—urinary bladder cancer	0.000999	0.0095	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000986	0.00938	CcSEcCtD
Rilpivirine—SLCO1B1—renal system—urinary bladder cancer	0.000962	0.0579	CbGeAlD
Rilpivirine—Abdominal pain—Valrubicin—urinary bladder cancer	0.000953	0.00907	CcSEcCtD
Rilpivirine—Inflammation—Etoposide—urinary bladder cancer	0.000867	0.00825	CcSEcCtD
Rilpivirine—Asthenia—Valrubicin—urinary bladder cancer	0.000865	0.00823	CcSEcCtD
Rilpivirine—Diarrhoea—Valrubicin—urinary bladder cancer	0.000825	0.00785	CcSEcCtD
Rilpivirine—Dizziness—Valrubicin—urinary bladder cancer	0.000798	0.00759	CcSEcCtD
Rilpivirine—Blood creatinine increased—Thiotepa—urinary bladder cancer	0.000796	0.00757	CcSEcCtD
Rilpivirine—ABCG2—prostate gland—urinary bladder cancer	0.00078	0.047	CbGeAlD
Rilpivirine—Transaminases increased—Epirubicin—urinary bladder cancer	0.000775	0.00737	CcSEcCtD
Rilpivirine—SLCO1B1—female reproductive system—urinary bladder cancer	0.00077	0.0464	CbGeAlD
Rilpivirine—Vomiting—Valrubicin—urinary bladder cancer	0.000767	0.00729	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—urinary bladder cancer	0.000767	0.00729	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.000766	0.00728	CcSEcCtD
Rilpivirine—Rash—Valrubicin—urinary bladder cancer	0.00076	0.00723	CcSEcCtD
Rilpivirine—Dermatitis—Valrubicin—urinary bladder cancer	0.00076	0.00723	CcSEcCtD
Rilpivirine—Headache—Valrubicin—urinary bladder cancer	0.000756	0.00719	CcSEcCtD
Rilpivirine—Renal impairment—Gemcitabine—urinary bladder cancer	0.000751	0.00715	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.00075	0.00713	CcSEcCtD
Rilpivirine—Somnolence—Mitomycin—urinary bladder cancer	0.000739	0.00703	CcSEcCtD
Rilpivirine—Decreased appetite—Mitomycin—urinary bladder cancer	0.000722	0.00687	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—urinary bladder cancer	0.000717	0.00682	CcSEcCtD
Rilpivirine—Nausea—Valrubicin—urinary bladder cancer	0.000716	0.00681	CcSEcCtD
Rilpivirine—Fatigue—Mitomycin—urinary bladder cancer	0.000716	0.00681	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—urinary bladder cancer	0.000709	0.00675	CcSEcCtD
Rilpivirine—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.00067	0.00637	CcSEcCtD
Rilpivirine—ABCG2—seminal vesicle—urinary bladder cancer	0.00066	0.0397	CbGeAlD
Rilpivirine—Hepatotoxicity—Methotrexate—urinary bladder cancer	0.000653	0.00621	CcSEcCtD
Rilpivirine—Renal failure—Thiotepa—urinary bladder cancer	0.000644	0.00612	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000644	0.00612	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000631	0.006	CcSEcCtD
Rilpivirine—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.000625	0.00594	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00062	0.00589	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.0006	0.00571	CcSEcCtD
Rilpivirine—Asthenia—Mitomycin—urinary bladder cancer	0.000596	0.00567	CcSEcCtD
Rilpivirine—Urinary tract disorder—Thiotepa—urinary bladder cancer	0.000581	0.00552	CcSEcCtD
Rilpivirine—Urethral disorder—Thiotepa—urinary bladder cancer	0.000577	0.00548	CcSEcCtD
Rilpivirine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000569	0.00541	CcSEcCtD
Rilpivirine—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000552	0.00525	CcSEcCtD
Rilpivirine—Dizziness—Mitomycin—urinary bladder cancer	0.000549	0.00523	CcSEcCtD
Rilpivirine—Renal failure—Gemcitabine—urinary bladder cancer	0.000542	0.00515	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.000539	0.00512	CcSEcCtD
Rilpivirine—Immune system disorder—Thiotepa—urinary bladder cancer	0.000531	0.00505	CcSEcCtD
Rilpivirine—Vomiting—Mitomycin—urinary bladder cancer	0.000528	0.00502	CcSEcCtD
Rilpivirine—Rash—Mitomycin—urinary bladder cancer	0.000524	0.00498	CcSEcCtD
Rilpivirine—Dermatitis—Mitomycin—urinary bladder cancer	0.000523	0.00498	CcSEcCtD
Rilpivirine—ABCG2—urethra—urinary bladder cancer	0.000522	0.0315	CbGeAlD
Rilpivirine—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.000521	0.00496	CcSEcCtD
Rilpivirine—Headache—Mitomycin—urinary bladder cancer	0.000521	0.00495	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—urinary bladder cancer	0.00052	0.00494	CcSEcCtD
Rilpivirine—Mental disorder—Thiotepa—urinary bladder cancer	0.000515	0.0049	CcSEcCtD
Rilpivirine—Malnutrition—Thiotepa—urinary bladder cancer	0.000512	0.00487	CcSEcCtD
Rilpivirine—CYP1A2—renal system—urinary bladder cancer	0.000512	0.0308	CbGeAlD
Rilpivirine—Renal failure—Cisplatin—urinary bladder cancer	0.000505	0.0048	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—urinary bladder cancer	0.000499	0.00474	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—urinary bladder cancer	0.000495	0.00471	CcSEcCtD
Rilpivirine—Nausea—Mitomycin—urinary bladder cancer	0.000494	0.00469	CcSEcCtD
Rilpivirine—CYP2B6—renal system—urinary bladder cancer	0.000491	0.0295	CbGeAlD
Rilpivirine—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.000489	0.00465	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—urinary bladder cancer	0.000486	0.00462	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000486	0.00462	CcSEcCtD
Rilpivirine—Urethral disorder—Gemcitabine—urinary bladder cancer	0.000485	0.00461	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—urinary bladder cancer	0.000466	0.00443	CcSEcCtD
Rilpivirine—Renal failure—Etoposide—urinary bladder cancer	0.000463	0.0044	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—urinary bladder cancer	0.000461	0.00439	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—urinary bladder cancer	0.000458	0.00436	CcSEcCtD
Rilpivirine—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.000455	0.00433	CcSEcCtD
Rilpivirine—CYP2C19—vagina—urinary bladder cancer	0.000454	0.0273	CbGeAlD
Rilpivirine—Urethral disorder—Cisplatin—urinary bladder cancer	0.000452	0.0043	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—urinary bladder cancer	0.00045	0.00428	CcSEcCtD
Rilpivirine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000447	0.00425	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000445	0.00423	CcSEcCtD
Rilpivirine—Anxiety—Thiotepa—urinary bladder cancer	0.000434	0.00413	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000433	0.00412	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—urinary bladder cancer	0.000431	0.0041	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—urinary bladder cancer	0.000417	0.00397	CcSEcCtD
Rilpivirine—Immune system disorder—Cisplatin—urinary bladder cancer	0.000417	0.00396	CcSEcCtD
Rilpivirine—Infection—Thiotepa—urinary bladder cancer	0.000415	0.00395	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—urinary bladder cancer	0.000414	0.00394	CcSEcCtD
Rilpivirine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00041	0.0039	CcSEcCtD
Rilpivirine—Skin disorder—Thiotepa—urinary bladder cancer	0.000406	0.00386	CcSEcCtD
Rilpivirine—Malnutrition—Cisplatin—urinary bladder cancer	0.000401	0.00382	CcSEcCtD
Rilpivirine—CYP2B6—female reproductive system—urinary bladder cancer	0.000393	0.0237	CbGeAlD
Rilpivirine—ABCG2—vagina—urinary bladder cancer	0.000385	0.0232	CbGeAlD
Rilpivirine—ABCB1—prostate gland—urinary bladder cancer	0.000385	0.0232	CbGeAlD
Rilpivirine—Immune system disorder—Etoposide—urinary bladder cancer	0.000382	0.00363	CcSEcCtD
Rilpivirine—Somnolence—Thiotepa—urinary bladder cancer	0.000371	0.00353	CcSEcCtD
Rilpivirine—CYP3A4—renal system—urinary bladder cancer	0.00037	0.0223	CbGeAlD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000364	0.00346	CcSEcCtD
Rilpivirine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000363	0.00345	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000361	0.00343	CcSEcCtD
Rilpivirine—Fatigue—Thiotepa—urinary bladder cancer	0.00036	0.00343	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—urinary bladder cancer	0.00036	0.00342	CcSEcCtD
Rilpivirine—CYP2B6—vagina—urinary bladder cancer	0.000355	0.0214	CbGeAlD
Rilpivirine—Infection—Gemcitabine—urinary bladder cancer	0.000349	0.00332	CcSEcCtD
Rilpivirine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000345	0.00328	CcSEcCtD
Rilpivirine—Infection—Fluorouracil—urinary bladder cancer	0.000343	0.00327	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000342	0.00325	CcSEcCtD
Rilpivirine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000341	0.00325	CcSEcCtD
Rilpivirine—Anxiety—Cisplatin—urinary bladder cancer	0.000341	0.00324	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000339	0.00323	CcSEcCtD
Rilpivirine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000339	0.00322	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—urinary bladder cancer	0.000333	0.00317	CcSEcCtD
Rilpivirine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00033	0.00314	CcSEcCtD
Rilpivirine—Infection—Cisplatin—urinary bladder cancer	0.000325	0.0031	CcSEcCtD
Rilpivirine—ABCB1—seminal vesicle—urinary bladder cancer	0.000325	0.0196	CbGeAlD
Rilpivirine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000321	0.00306	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000321	0.00305	CcSEcCtD
Rilpivirine—Skin disorder—Cisplatin—urinary bladder cancer	0.000318	0.00303	CcSEcCtD
Rilpivirine—Insomnia—Gemcitabine—urinary bladder cancer	0.000318	0.00302	CcSEcCtD
Rilpivirine—Insomnia—Fluorouracil—urinary bladder cancer	0.000313	0.00297	CcSEcCtD
Rilpivirine—Somnolence—Gemcitabine—urinary bladder cancer	0.000312	0.00297	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000311	0.00296	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000308	0.00293	CcSEcCtD
Rilpivirine—Somnolence—Fluorouracil—urinary bladder cancer	0.000307	0.00292	CcSEcCtD
Rilpivirine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000306	0.00291	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000303	0.00289	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000303	0.00288	CcSEcCtD
Rilpivirine—Fatigue—Gemcitabine—urinary bladder cancer	0.000303	0.00288	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000302	0.00287	CcSEcCtD
Rilpivirine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.0003	0.00286	CcSEcCtD
Rilpivirine—Asthenia—Thiotepa—urinary bladder cancer	0.0003	0.00285	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000298	0.00284	CcSEcCtD
Rilpivirine—Infection—Etoposide—urinary bladder cancer	0.000298	0.00284	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000297	0.00282	CcSEcCtD
Rilpivirine—CYP3A4—female reproductive system—urinary bladder cancer	0.000297	0.0179	CbGeAlD
Rilpivirine—Skin disorder—Etoposide—urinary bladder cancer	0.000292	0.00277	CcSEcCtD
Rilpivirine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000286	0.00272	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000285	0.00271	CcSEcCtD
Rilpivirine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000285	0.00271	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000283	0.00269	CcSEcCtD
Rilpivirine—ABCB1—epithelium—urinary bladder cancer	0.000283	0.017	CbGeAlD
Rilpivirine—Depression—Methotrexate—urinary bladder cancer	0.000281	0.00267	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000279	0.00266	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—urinary bladder cancer	0.000277	0.00264	CcSEcCtD
Rilpivirine—Dizziness—Thiotepa—urinary bladder cancer	0.000276	0.00263	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—urinary bladder cancer	0.000267	0.00254	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000267	0.00254	CcSEcCtD
Rilpivirine—Vomiting—Thiotepa—urinary bladder cancer	0.000266	0.00253	CcSEcCtD
Rilpivirine—Rash—Thiotepa—urinary bladder cancer	0.000263	0.00251	CcSEcCtD
Rilpivirine—Dermatitis—Thiotepa—urinary bladder cancer	0.000263	0.0025	CcSEcCtD
Rilpivirine—ABCB1—renal system—urinary bladder cancer	0.000262	0.0158	CbGeAlD
Rilpivirine—Headache—Thiotepa—urinary bladder cancer	0.000262	0.00249	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—urinary bladder cancer	0.000261	0.00248	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—urinary bladder cancer	0.000259	0.00247	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000259	0.00246	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—urinary bladder cancer	0.000259	0.00246	CcSEcCtD
Rilpivirine—ABCB1—urethra—urinary bladder cancer	0.000258	0.0155	CbGeAlD
Rilpivirine—Asthenia—Gemcitabine—urinary bladder cancer	0.000252	0.0024	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00025	0.00238	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000249	0.00237	CcSEcCtD
Rilpivirine—ABCG2—lymph node—urinary bladder cancer	0.000249	0.015	CbGeAlD
Rilpivirine—Nausea—Thiotepa—urinary bladder cancer	0.000248	0.00236	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000248	0.00236	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000245	0.00233	CcSEcCtD
Rilpivirine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000241	0.00229	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—urinary bladder cancer	0.00024	0.00228	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—urinary bladder cancer	0.000237	0.00226	CcSEcCtD
Rilpivirine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000236	0.00225	CcSEcCtD
Rilpivirine—Asthenia—Cisplatin—urinary bladder cancer	0.000235	0.00224	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000234	0.00222	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000232	0.00221	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000231	0.0022	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000229	0.00217	CcSEcCtD
Rilpivirine—Dizziness—Fluorouracil—urinary bladder cancer	0.000229	0.00217	CcSEcCtD
Rilpivirine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000224	0.00213	CcSEcCtD
Rilpivirine—Vomiting—Gemcitabine—urinary bladder cancer	0.000223	0.00213	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—urinary bladder cancer	0.000222	0.00211	CcSEcCtD
Rilpivirine—Rash—Gemcitabine—urinary bladder cancer	0.000222	0.00211	CcSEcCtD
Rilpivirine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000221	0.00211	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—urinary bladder cancer	0.00022	0.0021	CcSEcCtD
Rilpivirine—Headache—Gemcitabine—urinary bladder cancer	0.00022	0.00209	CcSEcCtD
Rilpivirine—Vomiting—Fluorouracil—urinary bladder cancer	0.00022	0.00209	CcSEcCtD
Rilpivirine—Rash—Fluorouracil—urinary bladder cancer	0.000218	0.00207	CcSEcCtD
Rilpivirine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000218	0.00207	CcSEcCtD
Rilpivirine—Headache—Fluorouracil—urinary bladder cancer	0.000217	0.00206	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000216	0.00206	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—urinary bladder cancer	0.000215	0.00205	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000215	0.00204	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000214	0.00203	CcSEcCtD
Rilpivirine—ABCB1—female reproductive system—urinary bladder cancer	0.00021	0.0126	CbGeAlD
Rilpivirine—Nausea—Gemcitabine—urinary bladder cancer	0.000209	0.00199	CcSEcCtD
Rilpivirine—Vomiting—Cisplatin—urinary bladder cancer	0.000208	0.00198	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—urinary bladder cancer	0.000207	0.00197	CcSEcCtD
Rilpivirine—Rash—Cisplatin—urinary bladder cancer	0.000207	0.00196	CcSEcCtD
Rilpivirine—Dermatitis—Cisplatin—urinary bladder cancer	0.000206	0.00196	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—urinary bladder cancer	0.000206	0.00196	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—urinary bladder cancer	0.000205	0.00195	CcSEcCtD
Rilpivirine—Nausea—Fluorouracil—urinary bladder cancer	0.000205	0.00195	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—urinary bladder cancer	0.000198	0.00189	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000198	0.00188	CcSEcCtD
Rilpivirine—Nausea—Cisplatin—urinary bladder cancer	0.000195	0.00185	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000192	0.00183	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—urinary bladder cancer	0.000191	0.00181	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000191	0.00181	CcSEcCtD
Rilpivirine—ABCB1—vagina—urinary bladder cancer	0.00019	0.0114	CbGeAlD
Rilpivirine—Rash—Etoposide—urinary bladder cancer	0.000189	0.0018	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—urinary bladder cancer	0.000189	0.0018	CcSEcCtD
Rilpivirine—Headache—Etoposide—urinary bladder cancer	0.000188	0.00179	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000186	0.00177	CcSEcCtD
Rilpivirine—Infection—Methotrexate—urinary bladder cancer	0.000179	0.0017	CcSEcCtD
Rilpivirine—Nausea—Etoposide—urinary bladder cancer	0.000178	0.0017	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000176	0.00168	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—urinary bladder cancer	0.000175	0.00166	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—urinary bladder cancer	0.000175	0.00166	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000174	0.00166	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—urinary bladder cancer	0.000172	0.00163	CcSEcCtD
Rilpivirine—Infection—Epirubicin—urinary bladder cancer	0.000167	0.00159	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000165	0.00157	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—urinary bladder cancer	0.000163	0.00155	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—urinary bladder cancer	0.000163	0.00155	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—urinary bladder cancer	0.000162	0.00154	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000161	0.00153	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—urinary bladder cancer	0.00016	0.00152	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000159	0.00151	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000156	0.00149	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000155	0.00148	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—urinary bladder cancer	0.000155	0.00147	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—urinary bladder cancer	0.000155	0.00147	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000153	0.00145	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—urinary bladder cancer	0.000152	0.00145	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000151	0.00144	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—urinary bladder cancer	0.00015	0.00142	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000147	0.0014	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000146	0.00139	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000145	0.00138	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—urinary bladder cancer	0.000145	0.00138	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000142	0.00135	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—urinary bladder cancer	0.000141	0.00134	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—urinary bladder cancer	0.000138	0.00132	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000138	0.00131	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000135	0.00129	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000134	0.00128	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—urinary bladder cancer	0.000134	0.00128	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000133	0.00126	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—urinary bladder cancer	0.000129	0.00123	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000127	0.00121	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000123	0.00117	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000123	0.00117	CcSEcCtD
Rilpivirine—ABCB1—lymph node—urinary bladder cancer	0.000123	0.0074	CbGeAlD
Rilpivirine—Asthenia—Epirubicin—urinary bladder cancer	0.000121	0.00115	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—urinary bladder cancer	0.000119	0.00113	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000115	0.00109	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—urinary bladder cancer	0.000114	0.00109	CcSEcCtD
Rilpivirine—Rash—Methotrexate—urinary bladder cancer	0.000113	0.00108	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—urinary bladder cancer	0.000113	0.00108	CcSEcCtD
Rilpivirine—Headache—Methotrexate—urinary bladder cancer	0.000113	0.00107	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—urinary bladder cancer	0.000112	0.00106	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—urinary bladder cancer	0.000111	0.00106	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—urinary bladder cancer	0.000107	0.00102	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—urinary bladder cancer	0.000107	0.00102	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000107	0.00101	CcSEcCtD
Rilpivirine—Rash—Epirubicin—urinary bladder cancer	0.000106	0.00101	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—urinary bladder cancer	0.000106	0.00101	CcSEcCtD
Rilpivirine—Headache—Epirubicin—urinary bladder cancer	0.000105	0.001	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—urinary bladder cancer	0.000103	0.000979	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—urinary bladder cancer	9.99e-05	0.00095	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—urinary bladder cancer	9.9e-05	0.000941	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—urinary bladder cancer	9.82e-05	0.000934	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—urinary bladder cancer	9.81e-05	0.000933	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—urinary bladder cancer	9.75e-05	0.000928	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—urinary bladder cancer	9.25e-05	0.000879	CcSEcCtD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	5.88e-05	0.000704	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	5.85e-05	0.000701	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	5.83e-05	0.000699	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	5.77e-05	0.000692	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	5.77e-05	0.000692	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.77e-05	0.000692	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—urinary bladder cancer	5.66e-05	0.000678	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	5.55e-05	0.000665	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ENO2—urinary bladder cancer	5.54e-05	0.000664	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—HPGDS—urinary bladder cancer	5.54e-05	0.000664	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.51e-05	0.00066	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—CREBBP—urinary bladder cancer	5.43e-05	0.000651	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	5.38e-05	0.000644	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTT1—urinary bladder cancer	5.38e-05	0.000644	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.36e-05	0.000642	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.3e-05	0.000635	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.3e-05	0.000634	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	5.28e-05	0.000632	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.17e-05	0.000619	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	5.15e-05	0.000617	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.04e-05	0.000603	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	4.96e-05	0.000594	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.95e-05	0.000593	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.91e-05	0.000588	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.89e-05	0.000585	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.87e-05	0.000583	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.78e-05	0.000572	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMP—urinary bladder cancer	4.77e-05	0.000572	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	4.75e-05	0.000569	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	4.66e-05	0.000558	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	4.6e-05	0.000551	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.52e-05	0.000541	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.49e-05	0.000538	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	4.49e-05	0.000538	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	4.47e-05	0.000535	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.46e-05	0.000534	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	4.37e-05	0.000524	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	4.36e-05	0.000523	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	4.36e-05	0.000523	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.34e-05	0.000519	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NAT2—urinary bladder cancer	4.32e-05	0.000517	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.29e-05	0.000514	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.27e-05	0.000511	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.26e-05	0.00051	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.26e-05	0.00051	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.21e-05	0.000505	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.15e-05	0.000497	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.09e-05	0.00049	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	4.02e-05	0.000482	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	3.99e-05	0.000478	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.89e-05	0.000466	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.78e-05	0.000453	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	3.73e-05	0.000447	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	3.73e-05	0.000446	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	3.73e-05	0.000446	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RRM2—urinary bladder cancer	3.72e-05	0.000446	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.7e-05	0.000444	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.62e-05	0.000434	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	3.61e-05	0.000433	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.61e-05	0.000432	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.59e-05	0.00043	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	3.59e-05	0.00043	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.57e-05	0.000428	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.56e-05	0.000426	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.51e-05	0.00042	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.5e-05	0.000419	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.49e-05	0.000418	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	3.47e-05	0.000415	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—HPGDS—urinary bladder cancer	3.45e-05	0.000413	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ENO2—urinary bladder cancer	3.45e-05	0.000413	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	3.43e-05	0.00041	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	3.43e-05	0.00041	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	3.4e-05	0.000407	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	3.4e-05	0.000407	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.39e-05	0.000406	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.38e-05	0.000405	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTT1—urinary bladder cancer	3.35e-05	0.000401	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.34e-05	0.0004	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.31e-05	0.000397	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.31e-05	0.000396	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	3.28e-05	0.000393	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.23e-05	0.000387	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—urinary bladder cancer	3.22e-05	0.000386	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	3.22e-05	0.000386	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.16e-05	0.000379	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.16e-05	0.000378	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.13e-05	0.000375	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.11e-05	0.000372	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.05e-05	0.000366	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.05e-05	0.000365	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	3.03e-05	0.000363	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	3e-05	0.00036	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.91e-05	0.000349	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.91e-05	0.000348	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.82e-05	0.000338	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.8e-05	0.000335	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.78e-05	0.000333	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.77e-05	0.000331	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.73e-05	0.000327	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.65e-05	0.000318	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.64e-05	0.000317	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.64e-05	0.000317	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.62e-05	0.000314	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.62e-05	0.000314	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.58e-05	0.000309	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.58e-05	0.000309	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.54e-05	0.000304	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.54e-05	0.000304	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.53e-05	0.000303	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.53e-05	0.000303	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.53e-05	0.000303	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	2.5e-05	0.0003	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.48e-05	0.000297	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	2.46e-05	0.000294	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.45e-05	0.000294	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.42e-05	0.00029	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.4e-05	0.000287	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.39e-05	0.000286	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	2.36e-05	0.000283	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.36e-05	0.000282	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.34e-05	0.00028	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.33e-05	0.000279	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	2.33e-05	0.000279	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTP1—urinary bladder cancer	2.32e-05	0.000278	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	2.3e-05	0.000276	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	2.3e-05	0.000276	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	2.2e-05	0.000264	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	2.16e-05	0.000259	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.16e-05	0.000259	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMS—urinary bladder cancer	2.16e-05	0.000258	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NCOR1—urinary bladder cancer	2.13e-05	0.000255	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—urinary bladder cancer	2.13e-05	0.000255	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.08e-05	0.000249	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.07e-05	0.000247	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.06e-05	0.000247	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.06e-05	0.000247	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GPX1—urinary bladder cancer	2.04e-05	0.000244	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.04e-05	0.000244	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.04e-05	0.000244	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	2.03e-05	0.000244	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.01e-05	0.000241	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.00024	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.99e-05	0.000238	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.98e-05	0.000237	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.93e-05	0.000231	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.91e-05	0.000229	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.91e-05	0.000229	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.9e-05	0.000228	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000226	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.87e-05	0.000223	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.87e-05	0.000223	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.86e-05	0.000223	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.85e-05	0.000222	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.82e-05	0.000219	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.81e-05	0.000217	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.7e-05	0.000204	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.69e-05	0.000203	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.68e-05	0.000202	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.65e-05	0.000198	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.61e-05	0.000193	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.61e-05	0.000192	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.59e-05	0.00019	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.58e-05	0.00019	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.58e-05	0.000189	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.56e-05	0.000187	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.56e-05	0.000187	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.54e-05	0.000185	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.53e-05	0.000183	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.5e-05	0.00018	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.5e-05	0.000179	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.49e-05	0.000179	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.49e-05	0.000178	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.49e-05	0.000178	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.48e-05	0.000177	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.47e-05	0.000176	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.47e-05	0.000176	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.44e-05	0.000173	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.44e-05	0.000172	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.42e-05	0.00017	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.38e-05	0.000165	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.3e-05	0.000156	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.3e-05	0.000155	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.28e-05	0.000154	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	0.00015	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.24e-05	0.000149	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.24e-05	0.000149	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	0.000144	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.2e-05	0.000144	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.19e-05	0.000143	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	0.000141	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	0.000141	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.17e-05	0.00014	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.16e-05	0.000139	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.15e-05	0.000138	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	1.13e-05	0.000136	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.13e-05	0.000135	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.12e-05	0.000134	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.11e-05	0.000134	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	0.000133	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.1e-05	0.000132	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	0.00013	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	1.08e-05	0.000129	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000129	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.05e-05	0.000126	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	0.000125	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	0.000122	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.02e-05	0.000122	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1e-05	0.00012	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—urinary bladder cancer	9.99e-06	0.00012	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.68e-06	0.000116	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	9.31e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.26e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	9.2e-06	0.00011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	9.2e-06	0.00011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	8.81e-06	0.000106	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	8.81e-06	0.000106	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	8.65e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.46e-06	0.000101	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.26e-06	9.89e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	8.13e-06	9.74e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.13e-06	9.74e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.93e-06	9.5e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.73e-06	9.25e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	7.68e-06	9.2e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—urinary bladder cancer	7.32e-06	8.77e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.18e-06	8.6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.1e-06	8.5e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.1e-06	8.5e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.8e-06	8.14e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.67e-06	8e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.66e-06	7.97e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.59e-06	7.9e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.5e-06	7.78e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.33e-06	7.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.27e-06	7.52e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.8e-06	6.95e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.66e-06	6.79e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.54e-06	6.63e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—urinary bladder cancer	5.4e-06	6.47e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.19e-06	6.21e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.09e-06	6.09e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.89e-06	5.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.52e-06	5.42e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.31e-06	5.17e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4e-06	4.79e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.49e-06	4.18e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.33e-06	3.99e-05	CbGpPWpGaD
